Postoperative Pain Management Market

Market Study on Postoperative Pain Management: North America to Remain Leading Regional Market

Postoperative Pain Management Market Segmented By Opioids, NSAIDS, Local Anaesthetics, and Acetaminophen Drugs in Injectable, Oral, Topical, Transdermal Route of Administration

- Table of Content -

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Key Development Trends

4. Market Background

    4.1. Macro-Economic Factors

        4.1.1. Global GDP Growth Outlook

        4.1.2. Global Healthcare Expenditure Outlook

        4.1.3. Emerging Countries Healthcare and Development Outlook

    4.2. Forecast Factors - Relevance & Impact

        4.2.1. Average Annual Spending on Pain Management Drugs

        4.2.2. Average Healthcare Expenditure

        4.2.3. Increasing Prevalence of Chronic and Acute Diseases

        4.2.4. Growing Number of Patients undergoing Surgical Interventions

        4.2.5. Rising Number of Population Suffering from End-stage Diseases

        4.2.6. Per Capita Pharmaceutical Expenditure

        4.2.7. Awareness for Pain Management Drugs

        4.2.8. Favourable Reimbursement Policies

        4.2.9. Regulatory Control over Prescription

        4.2.10. Popularity of Generic Products

        4.2.11. Patent Expiration of Novel Pain Management Drugs (Opioids)

        4.2.12. Introduction of Novel Abuse-deterrent Pain Management Drugs

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Trends

        4.3.4. Opportunity Analysis

5. Market Context

    5.1. Promotional and Marketing Strategies, By Key Services Providers

    5.2. Description of Industry Evolution and Main developments

    5.3. Regulatory Scenario

    5.4. Technological Evaluation and Advancements

    5.5. Key Industry Events

    5.6. Porter’s Five Force Analysis

6. COVID19 Crisis Analysis

    6.1. Current COVID19 Statistics and Probable Future Impact

    6.2. Current GDP Projection and Probable Impact

    6.3. Current Economic Projection as compared to 2008 financial analysis

    6.4. COVID19 and Impact Analysis

        6.4.1. Revenue By Drug Class

        6.4.2. Revenue By Route of Administration

        6.4.3. Revenue By Distribution Channel

        6.4.4. Revenue By Country

    6.5. 2022 Market Scenario

    6.6. Quarter by Quarter Forecast

    6.7. Projected recovery Quarter

    6.8. Recovery Scenario- Short term, Midterm and Long Term Impact

7. Global Postoperative Pain Management Market Value (US$ Mn) Analysis 2016-2021 and Forecast, 2022-2031

    7.1. Historical Market Value (US$ Mn) Analysis, 2016-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2031

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Postoperative Pain Management Market Analysis 2016-2021 and Forecast 2022-2031, By Drug Class

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis, By Drug Class, 2016 - 2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Class, 2022 - 2031

        8.3.1. Opioids

        8.3.2. NSAIDS

        8.3.3. Local Anaesthetics

        8.3.4. Acetaminophen

    8.4. Market Attractiveness Analysis By Drug Class

9. Global Postoperative Pain Management Market Analysis 2016-2021 and Forecast 2022-2031, By Route of Administration

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis, By Route of Administration, 2016 - 2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Route of Administration, 2022 - 2031

        9.3.1. Injectable

        9.3.2. Oral

        9.3.3. Topical

        9.3.4. Transdermal

        9.3.5. Others

    9.4. Market Attractiveness Analysis By Route of Administration

10. Global Postoperative Pain Management Market Analysis 2016-2021 and Forecast 2022-2031, By Distribution Channel

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2016 - 2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2031

        10.3.1. Hospital Pharmacies

        10.3.2. Retail Pharmacies

        10.3.3. Drug Store

        10.3.4. Clinics

        10.3.5. Others

    10.4. Market Attractiveness Analysis By Distribution Channel

11. Global Postoperative Pain Management Market Analysis 2016-2021 and Forecast 2022-2031, by Region

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Region, 2016 - 2021

    11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022 - 2031

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. South Asia

        11.3.5. East Asia

        11.3.6. Oceania

        11.3.7. Middle East and Africa (MEA)

    11.4. Market Attractiveness Analysis By Region

12. North America Postoperative Pain Management Market Analysis 2016-2021 and Forecast 2022-2031

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016 - 2021

    12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2031

        12.3.1. By Country

            12.3.1.1. U.S.

            12.3.1.2. Canada

        12.3.2. By Drug Class

        12.3.3. By Route of Administration

        12.3.4. By Distribution Channel

    12.4. Market Attractiveness Analysis

    12.5. Key Market Participants - Intensity Mapping

    12.6. Drivers and Restraints - Impact Analysis

13. Latin America Postoperative Pain Management Market Analysis 2016-2021 and Forecast 2022-2031

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016 - 2021

    13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2031

        13.3.1. By Country

            13.3.1.1. Brazil

            13.3.1.2. Mexico

            13.3.1.3. Argentina

            13.3.1.4. Rest of Latin America

        13.3.2. By Drug Class

        13.3.3. By Route of Administration

        13.3.4. By Distribution Channel

    13.4. Market Attractiveness Analysis

    13.5. Key Market Participants - Intensity Mapping

    13.6. Drivers and Restraints - Impact Analysis

14. Europe Postoperative Pain Management Market Analysis 2016-2021 and Forecast 2022-2031

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016 - 2021

    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2031

        14.3.1. By Country

            14.3.1.1. U.K.

            14.3.1.2. Germany

            14.3.1.3. France

            14.3.1.4. Italy

            14.3.1.5. Spain

            14.3.1.6. Russia

            14.3.1.7. BENELUX

            14.3.1.8. Rest of Europe

        14.3.2. By Drug Class

        14.3.3. By Route of Administration

        14.3.4. By Distribution Channel

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. South Asia Postoperative Pain Management Market Analysis 2016-2021 and Forecast 2022-2031

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016 - 2021

    15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2031

        15.3.1. By Country

            15.3.1.1. India

            15.3.1.2. Thailand

            15.3.1.3. Indonesia

            15.3.1.4. Malaysia

            15.3.1.5. Rest of South Asia

        15.3.2. By Drug Class

        15.3.3. By Route of Administration

        15.3.4. By Distribution Channel

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. East Asia Postoperative Pain Management Market Analysis 2016-2021 and Forecast 2022-2031

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016 - 2021

    16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2031

        16.3.1. By Country

            16.3.1.1. China

            16.3.1.2. Japan

            16.3.1.3. South Korea

            16.3.1.4. Rest of East Asia

        16.3.2. By Drug Class

        16.3.3. By Route of Administration

        16.3.4. By Distribution Channel

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. Oceania Postoperative Pain Management Market Analysis 2016-2021 and Forecast 2022-2031

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016 - 2021

    17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2031

        17.3.1. By Country

            17.3.1.1. Australia

            17.3.1.2. New Zealand

        17.3.2. By Drug Class

        17.3.3. By Route of Administration

        17.3.4. By Distribution Channel

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Postoperative Pain Management Market Analysis 2016-2021 and Forecast 2022-2031

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016 - 2021

    18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2031

        18.3.1. By Country

            18.3.1.1. GCC Countries

            18.3.1.2. Turkey

            18.3.1.3. Northern Africa

            18.3.1.4. South Africa

            18.3.1.5. Rest of Middle East and Africa

        18.3.2. By Drug Class

        18.3.3. By Route of Administration

        18.3.4. By Distribution Channel

    18.4. Market Attractiveness Analysis

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. Emerging Countries Postoperative Pain Management Market Analysis 2022 & 2031

    19.1. Introduction

        19.1.1. Market Value Proportion Analysis, By Key Countries

        19.1.2. Global Vs. Country Growth Comparison

    19.2. U.S. Postoperative Pain Management Market Analysis

        19.2.1. By Drug Class

        19.2.2. By Route of Administration

        19.2.3. By Distribution Channel

    19.3. Canada Postoperative Pain Management Market Analysis

        19.3.1. By Drug Class

        19.3.2. By Route of Administration

        19.3.3. By Distribution Channel

    19.4. Mexico Postoperative Pain Management Market Analysis

        19.4.1. By Drug Class

        19.4.2. By Route of Administration

        19.4.3. By Distribution Channel

    19.5. Brazil Postoperative Pain Management Market Analysis

        19.5.1. By Drug Class

        19.5.2. By Route of Administration

        19.5.3. By Distribution Channel

    19.6. U.K. Postoperative Pain Management Market Analysis

        19.6.1. By Drug Class

        19.6.2. By Route of Administration

        19.6.3. By Distribution Channel

    19.7. Germany Postoperative Pain Management Market Analysis

        19.7.1. By Drug Class

        19.7.2. By Route of Administration

        19.7.3. By Distribution Channel

    19.8. France Postoperative Pain Management Market Analysis

        19.8.1. By Drug Class

        19.8.2. By Route of Administration

        19.8.3. By Distribution Channel

    19.9. Italy Postoperative Pain Management Market Analysis

        19.9.1. By Drug Class

        19.9.2. By Route of Administration

        19.9.3. By Distribution Channel

    19.10. Spain Postoperative Pain Management Market Analysis

        19.10.1. By Drug Class

        19.10.2. By Route of Administration

        19.10.3. By Distribution Channel

    19.11. BENELUX Postoperative Pain Management Market Analysis

        19.11.1. By Drug Class

        19.11.2. By Route of Administration

        19.11.3. By Distribution Channel

    19.12. Russia Postoperative Pain Management Market Analysis

        19.12.1. By Drug Class

        19.12.2. By Route of Administration

        19.12.3. By Distribution Channel

    19.13. China Postoperative Pain Management Market Analysis

        19.13.1. By Drug Class

        19.13.2. By Route of Administration

        19.13.3. By Distribution Channel

    19.14. Japan Postoperative Pain Management Market Analysis

        19.14.1. By Drug Class

        19.14.2. By Route of Administration

        19.14.3. By Distribution Channel

    19.15. South Korea Postoperative Pain Management Market Analysis

        19.15.1. By Drug Class

        19.15.2. By Route of Administration

        19.15.3. By Distribution Channel

    19.16. India Postoperative Pain Management Market Analysis

        19.16.1. By Drug Class

        19.16.2. By Route of Administration

        19.16.3. By Distribution Channel

    19.17. ASEAN Postoperative Pain Management Market Analysis

        19.17.1. By Drug Class

        19.17.2. By Route of Administration

        19.17.3. By Distribution Channel

    19.18. Australia Postoperative Pain Management Market Analysis

        19.18.1. By Drug Class

        19.18.2. By Route of Administration

        19.18.3. By Distribution Channel

    19.19. New Zealand Postoperative Pain Management Market Analysis

        19.19.1. By Drug Class

        19.19.2. By Route of Administration

        19.19.3. By Distribution Channel

    19.20. GCC Countries Postoperative Pain Management Market Analysis

        19.20.1. By Drug Class

        19.20.2. By Route of Administration

        19.20.3. By Distribution Channel

    19.21. Turkey Postoperative Pain Management Market Analysis

        19.21.1. By Drug Class

        19.21.2. By Route of Administration

        19.21.3. By Distribution Channel

    19.22. South Africa Postoperative Pain Management Market Analysis

        19.22.1. By Drug Class

        19.22.2. By Route of Administration

        19.22.3. By Distribution Channel

20. Market Structure Analysis

    20.1. Market Analysis by Tier of Companies 

    20.2. Market Share Analysis of Top Players

    20.3. Market Concentration

    20.4. Market Presence Analysis

        20.4.1. By Regional footprint of Players

        20.4.2. Product foot print by Players

        20.4.3. Channel Foot Print by Players

21. Competition Analysis

    21.1. Competition Dashboard

    21.2. Competition Benchmarking

    21.3. Competition Deep Dive

        21.3.1. Teva Pharmaceutical Industries Ltd.

            21.3.1.1. Overview

            21.3.1.2. Services Portfolio

            21.3.1.3. Analyst Commentary

            21.3.1.4. Key Financials

            21.3.1.5. Recent Developments

            21.3.1.6. Sales Footprint

            21.3.1.7. Strategy Overview

                21.3.1.7.1. Marketing Strategy

                21.3.1.7.2. Services Strategy

                21.3.1.7.3. Channel Strategy

        21.3.2. Novartis AG

            21.3.2.1. Overview

            21.3.2.2. Services Portfolio

            21.3.2.3. Analyst Commentary

            21.3.2.4. Key Financials

            21.3.2.5. Recent Developments

            21.3.2.6. Sales Footprint

            21.3.2.7. Strategy Overview

                21.3.2.7.1. Marketing Strategy

                21.3.2.7.2. Services Strategy

                21.3.2.7.3. Channel Strategy

        21.3.3. Allergan plc

            21.3.3.1. Overview

            21.3.3.2. Services Portfolio

            21.3.3.3. Analyst Commentary

            21.3.3.4. Key Financials

            21.3.3.5. Recent Developments

            21.3.3.6. Sales Footprint

            21.3.3.7. Strategy Overview

                21.3.3.7.1. Marketing Strategy

                21.3.3.7.2. Services Strategy

                21.3.3.7.3. Channel Strategy

        21.3.4. Mylan N.V

            21.3.4.1. Overview

            21.3.4.2. Services Portfolio

            21.3.4.3. Analyst Commentary

            21.3.4.4. Key Financials

            21.3.4.5. Recent Developments

            21.3.4.6. Sales Footprint

            21.3.4.7. Strategy Overview

                21.3.4.7.1. Marketing Strategy

                21.3.4.7.2. Services Strategy

                21.3.4.7.3. Channel Strategy

        21.3.5. Pfizer Inc.

            21.3.5.1. Overview

            21.3.5.2. Services Portfolio

            21.3.5.3. Analyst Commentary

            21.3.5.4. Key Financials

            21.3.5.5. Recent Developments

            21.3.5.6. Sales Footprint

            21.3.5.7. Strategy Overview

                21.3.5.7.1. Marketing Strategy

                21.3.5.7.2. Services Strategy

                21.3.5.7.3. Channel Strategy

        21.3.6. Purdue Pharma L.P

            21.3.6.1. Overview

            21.3.6.2. Services Portfolio

            21.3.6.3. Analyst Commentary

            21.3.6.4. Key Financials

            21.3.6.5. Recent Developments

            21.3.6.6. Sales Footprint

            21.3.6.7. Strategy Overview

                21.3.6.7.1. Marketing Strategy

                21.3.6.7.2. Services Strategy

                21.3.6.7.3. Channel Strategy

        21.3.7. Janssen Pharmaceuticals, Inc.

            21.3.7.1. Overview

            21.3.7.2. Services Portfolio

            21.3.7.3. Analyst Commentary 

            21.3.7.4. Key Financials

            21.3.7.5. Recent Developments

            21.3.7.6. Sales Footprint

            21.3.7.7. Strategy Overview

                21.3.7.7.1. Marketing Strategy

                21.3.7.7.2. Services Strategy

                21.3.7.7.3. Channel Strategy

        21.3.8. Endo International plc

            21.3.8.1. Overview

            21.3.8.2. Services Portfolio

            21.3.8.3. Analyst Commentary

            21.3.8.4. Key Financials

            21.3.8.5. Recent Developments

            21.3.8.6. Sales Footprint

            21.3.8.7. Strategy Overview

                21.3.8.7.1. Marketing Strategy

                21.3.8.7.2. Services Strategy

                21.3.8.7.3. Channel Strategy

        21.3.9. Pacira Pharmaceuticals Inc.

            21.3.9.1. Overview

            21.3.9.2. Services Portfolio

            21.3.9.3. Analyst Commentary

            21.3.9.4. Key Financials

            21.3.9.5. Recent Developments

            21.3.9.6. Sales Footprint

            21.3.9.7. Strategy Overview

                21.3.9.7.1. Marketing Strategy

                21.3.9.7.2. Services Strategy

                21.3.9.7.3. Channel Strategy

        21.3.10. Egalet Corporation

            21.3.10.1. Overview

            21.3.10.2. Services Portfolio

            21.3.10.3. Analyst Commentary

            21.3.10.4. Key Financials

            21.3.10.5. Recent Developments

            21.3.10.6. Sales Footprint

            21.3.10.7. Strategy Overview

                21.3.10.7.1. Marketing Strategy

                21.3.10.7.2. Services Strategy

                21.3.10.7.3. Channel Strategy

        21.3.11. GlaxoSmithKline Plc.

            21.3.11.1. Overview

            21.3.11.2. Services Portfolio

            21.3.11.3. Analyst Commentary

            21.3.11.4. Key Financials

            21.3.11.5. Recent Developments

            21.3.11.6. Sales Footprint

            21.3.11.7. Strategy Overview

                21.3.11.7.1. Marketing Strategy

                21.3.11.7.2. Services Strategy

                21.3.11.7.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology

Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

- List Of Table -

Table 1: Global Postoperative Pain Management Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Drug Class

Table 2: Global Postoperative Pain Management Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Route of Administration

Table 3: Global Postoperative Pain Management Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Distribution Channel

Table 4: Global Postoperative Pain Management Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Region

Table 5: North America Postoperative Pain Management Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Drug Class

Table 6: North America Postoperative Pain Management Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Route of Administration

Table 7: North America Postoperative Pain Management Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Distribution Channel

Table 8: North America Postoperative Pain Management Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Country

Table 9: Latin America Postoperative Pain Management Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Drug Class

Table 10: Latin America Postoperative Pain Management Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Route of Administration

Table 11: Latin America Postoperative Pain Management Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Distribution Channel

Table 12: Latin America Postoperative Pain Management Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Country

Table 13: Europe Postoperative Pain Management Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Drug Class

Table 14: Europe Postoperative Pain Management Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Route of Administration

Table 15: Europe Postoperative Pain Management Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Distribution Channel

Table 16: Europe Postoperative Pain Management Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Country

Table 17: East Asia Postoperative Pain Management Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Drug Class

Table 18: East Asia Postoperative Pain Management Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Route of Administration

Table 19: East Asia Postoperative Pain Management Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Distribution Channel

Table 20: East Asia Postoperative Pain Management Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Country

Table 21: South Asia Postoperative Pain Management Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Drug Class

Table 22: South Asia Postoperative Pain Management Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Route of Administration

Table 23: South Asia Postoperative Pain Management Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Distribution Channel

Table 24: South Asia Postoperative Pain Management Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Country

Table 25: Oceania Postoperative Pain Management Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Drug Class

Table 26: Oceania Postoperative Pain Management Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Route of Administration

Table 27: Oceania Postoperative Pain Management Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Distribution Channel

Table 28: Oceania Postoperative Pain Management Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Country

Table 29: MEA Postoperative Pain Management Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Drug Class

Table 30: MEA Postoperative Pain Management Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Route of Administration

Table 31: MEA Postoperative Pain Management Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Distribution Channel

Table 32: MEA Postoperative Pain Management Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Country

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

- List Of Chart -

Figure 1: Global Postoperative Pain Management Market Historical Market Value (US$ Mn) Analysis, 2016-2021

Figure 2: Global Postoperative Pain Management Current and Future Market Value (US$ Mn), 2022-2031 & Y-o-Y Growth Trend Analysis

Figure 3: Postoperative Pain Management Market Absolute $ Opportunity, 2022-2031

Figure 4: Global Postoperative Pain Management Market Share Analysis (%) By Drug Class, 2022 & 2031

Figure 5: Global Postoperative Pain Management Market Y-o-Y Growth (%) By Drug Class, 2022-2031

Figure 6: Global Postoperative Pain Management Market Attractiveness Analysis, By Drug Class

Figure 7: Global Postoperative Pain Management Market Share Analysis (%) By Route of Administration, 2022 & 2031

Figure 8: Global Postoperative Pain Management Market Y-o-Y Growth (%) By Route of Administration, 2022-2031

Figure 9: Global Postoperative Pain Management Market Attractiveness Analysis, By Route of Administration

Figure 10: Global Postoperative Pain Management Market Share Analysis (%) By Distribution Channel, 2022 & 2031

Figure 11: Global Postoperative Pain Management Market Y-o-Y Growth (%) By Distribution Channel, 2022-2031

Figure 12: Global Postoperative Pain Management Market Attractiveness Analysis, By Distribution Channel

Figure 13: Global Postoperative Pain Management Market Share Analysis (%) By Region, 2022 & 2031

Figure 14: Global Postoperative Pain Management Market Y-o-Y Growth (%) By Region, 2022-2031

Figure 15: Global Postoperative Pain Management Market Attractiveness Analysis, By Region

Figure 16: North America Postoperative Pain Management Market Share, By Drug Class (2022)

Figure 17: North America Postoperative Pain Management Market Share, By Route of Administration (2022)

Figure 18: North America Postoperative Pain Management Market Share, By Distribution Channel (2022)

Figure 19: North America Postoperative Pain Management Market Share, By Country (2022)

Figure 20: North America Postoperative Pain Management Market Value (US$ Mn) Analysis, 2016-2021

Figure 21: North America Postoperative Pain Management Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2031

Figure 22: North America Postoperative Pain Management Market Attractiveness Analysis, By Country

Figure 23: North America Postoperative Pain Management Market Attractiveness Analysis, By Drug Class

Figure 24: North America Postoperative Pain Management Market Attractiveness Analysis, By Route of Administration

Figure 25: North America Postoperative Pain Management Market Attractiveness Analysis, By Distribution Channel

Figure 26: Latin America Postoperative Pain Management Market Share, By Drug Class (2022)

Figure 27: Latin America Postoperative Pain Management Market Share, By Route of Administration (2022)

Figure 28: Latin America Postoperative Pain Management Market Share, By Distribution Channel (2022)

Figure 29: Latin America Postoperative Pain Management Market Share, By Country (2022)

Figure 30: Latin America Postoperative Pain Management Market Value (US$ Mn) Analysis, 2016-2021

Figure 31: Latin America Postoperative Pain Management Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2031

Figure 32: Latin America Postoperative Pain Management Market Attractiveness Analysis, By Country

Figure 33: Latin America Postoperative Pain Management Market Attractiveness Analysis, By Drug Class

Figure 34: Latin America Postoperative Pain Management Market Attractiveness Analysis, By Route of Administration

Figure 35: Latin America Postoperative Pain Management Market Attractiveness Analysis, By Distribution Channel

Figure 36: Europe Postoperative Pain Management Market Share, By Drug Class (2022)

Figure 37: Europe Postoperative Pain Management Market Share, By Route of Administration (2022)

Figure 38: Europe Postoperative Pain Management Market Share, By Distribution Channel (2022)

Figure 39: Europe Postoperative Pain Management Market Share, By Country (2022)

Figure 40: Europe Postoperative Pain Management Market Value (US$ Mn) Analysis, 2016-2021

Figure 41: Europe Postoperative Pain Management Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2031

Figure 42: Europe Postoperative Pain Management Market Attractiveness Analysis, By Country

Figure 43: Europe Postoperative Pain Management Market Attractiveness Analysis, By Drug Class

Figure 44: Europe Postoperative Pain Management Market Attractiveness Analysis, By Route of Administration

Figure 45: Europe Postoperative Pain Management Market Attractiveness Analysis, By Distribution Channel

Figure 46: East Asia Postoperative Pain Management Market Share, By Drug Class (2022)

Figure 47: East Asia Postoperative Pain Management Market Share, By Route of Administration (2022)

Figure 48: East Asia Postoperative Pain Management Market Share, By Distribution Channel (2022)

Figure 49: East Asia Postoperative Pain Management Market Share, By Country (2022)

Figure 50: East Asia Postoperative Pain Management Market Value (US$ Mn) Analysis, 2016-2021

Figure 51: East Asia Postoperative Pain Management Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2031

Figure 52: East Asia Postoperative Pain Management Market Attractiveness Analysis, By Country

Figure 53: East Asia Postoperative Pain Management Market Attractiveness Analysis, By Drug Class

Figure 54: East Asia Postoperative Pain Management Market Attractiveness Analysis, By Route of Administration

Figure 55: East Asia Postoperative Pain Management Market Attractiveness Analysis, By Distribution Channel

Figure 56: South Asia Postoperative Pain Management Market Share, By Drug Class (2022)

Figure 57: South Asia Postoperative Pain Management Market Share, By Route of Administration (2022)

Figure 59: South Asia Postoperative Pain Management Market Share, By Distribution Channel (2022)

Figure 58: South Asia Postoperative Pain Management Market Share, By Country (2022)

Figure 60: South Asia Postoperative Pain Management Market Value (US$ Mn) Analysis, 2016-2021

Figure 61: South Asia Postoperative Pain Management Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2031

Figure 63: South Asia Postoperative Pain Management Market Attractiveness Analysis, By Country

Figure 64: South Asia Postoperative Pain Management Market Attractiveness Analysis, By Drug Class

Figure 65: South Asia Postoperative Pain Management Market Attractiveness Analysis, By Route of Administration

Figure 66: South Asia Postoperative Pain Management Market Attractiveness Analysis, By Distribution Channel

Figure 67: Oceania Postoperative Pain Management Market Share, By Drug Class (2022)

Figure 68: Oceania Postoperative Pain Management Market Share, By Route of Administration (2022)

Figure 69: Oceania Postoperative Pain Management Market Share, By Distribution Channel (2022)

Figure 70: Oceania Postoperative Pain Management Market Share, By Country (2022)

Figure 71: Oceania Postoperative Pain Management Market Value (US$ Mn) Analysis, 2016-2021

Figure 72: Oceania Postoperative Pain Management Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2031

Figure 73: Oceania Postoperative Pain Management Market Attractiveness Analysis, By Country

Figure 74: Oceania Postoperative Pain Management Market Attractiveness Analysis, By Drug Class

Figure 75: Oceania Postoperative Pain Management Market Attractiveness Analysis, By Route of Administration

Figure 76: Oceania Postoperative Pain Management Market Attractiveness Analysis, By Distribution Channel

Figure 77: MEA Postoperative Pain Management Market Share, By Drug Class (2022)

Figure 78: MEA Postoperative Pain Management Market Share, By Route of Administration (2022)

Figure 79: MEA Postoperative Pain Management Market Share, By Distribution Channel (2022)

Figure 80: MEA Postoperative Pain Management Market Share, By Country (2022)

Figure 81: MEA Postoperative Pain Management Market Value (US$ Mn) Analysis, 2016-2021

Figure 82: MEA Postoperative Pain Management Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2031

Figure 83: MEA Postoperative Pain Management Market Attractiveness Analysis, By Country

Figure 84: MEA Postoperative Pain Management Market Attractiveness Analysis, By Drug Class

Figure 85: MEA Postoperative Pain Management Market Attractiveness Analysis, By Route of Administration

Figure 86: MEA Postoperative Pain Management Market Attractiveness Analysis, By Distribution Channel

Figure 87: U.S. Market Value Proportion Analysis

Figure 88: Global Vs. U.S Growth Comparison

Figure 89: U.S. Postoperative Pain Management Market Share Analysis (%) By Drug Class, 2022 & 2031

Figure 90: U.S. Postoperative Pain Management Market Share Analysis (%) By Route of Administration, 2022 & 2031

Figure 91: U.S. Postoperative Pain Management Market Share Analysis (%) By Distribution Channel, 2022 & 2031

Figure 92: Canada Market Value Proportion Analysis

Figure 93: Global Vs. Canada Growth Comparison

Figure 94: Canada Postoperative Pain Management Market Share Analysis (%) By Drug Class, 2022 & 2031

Figure 95: Canada Postoperative Pain Management Market Share Analysis (%) By Route of Administration, 2022 & 2031

Figure 96: Canada Postoperative Pain Management Market Share Analysis (%) By Distribution Channel, 2022 & 2031

Figure 97: Brazil Market Value Proportion Analysis

Figure 98: Global Vs. Brazil Growth Comparison

Figure 99: Brazil Postoperative Pain Management Market Share Analysis (%) By Drug Class, 2022 & 2031

Figure 100: Brazil Postoperative Pain Management Market Share Analysis (%) By Route of Administration, 2022 & 2031

Figure 101: Brazil Postoperative Pain Management Market Share Analysis (%) By Distribution Channel, 2022 & 2031

Figure 102: Mexico Market Value Proportion Analysis

Figure 103: Global Vs. Mexico Growth Comparison

Figure 104: Mexico Postoperative Pain Management Market Share Analysis (%) By Drug Class, 2022 & 2031

Figure 105: Mexico Postoperative Pain Management Market Share Analysis (%) By Route of Administration, 2022 & 2031

Figure 106: Mexico Postoperative Pain Management Market Share Analysis (%) By Distribution Channel, 2022 & 2031

Figure 107: U.K. Market Value Proportion Analysis

Figure 108: Global Vs. U.K. Growth Comparison

Figure 109: U.K. Postoperative Pain Management Market Share Analysis (%) By Drug Class, 2022 & 2031

Figure 110: U.K. Postoperative Pain Management Market Share Analysis (%) By Route of Administration, 2022 & 2031

Figure 111: U.K. Postoperative Pain Management Market Share Analysis (%) By Distribution Channel, 2022 & 2031

Figure 112: Germany Market Value Proportion Analysis

Figure 113: Global Vs. Germany Growth Comparison

Figure 114: Germany Postoperative Pain Management Market Share Analysis (%) By Drug Class, 2022 & 2031

Figure 115: Germany Postoperative Pain Management Market Share Analysis (%) By Route of Administration, 2022 & 2031

Figure 116: Germany Postoperative Pain Management Market Share Analysis (%) By Distribution Channel, 2022 & 2031

Figure 117: Italy Market Value Proportion Analysis

Figure 118: Global Vs. Italy Growth Comparison

Figure 119: Italy Postoperative Pain Management Market Share Analysis (%) By Drug Class, 2022 & 2031

Figure 120: Italy Postoperative Pain Management Market Share Analysis (%) By Route of Administration, 2022 & 2031

Figure 121: Italy Postoperative Pain Management Market Share Analysis (%) By Distribution Channel, 2022 & 2031

Figure 122:France Market Value Proportion Analysis

Figure 123: Global Vs. France Growth Comparison

Figure 124: France Postoperative Pain Management Market Share Analysis (%) By Drug Class, 2022 & 2031

Figure 125: France Postoperative Pain Management Market Share Analysis (%) By Route of Administration, 2022 & 2031

Figure 126: France Postoperative Pain Management Market Share Analysis (%) By Distribution Channel, 2022 & 2031

Figure 127: BENELUX Market Value Proportion Analysis

Figure 128: Global Vs. BENELUX Growth Comparison

Figure 129: BENELUX Postoperative Pain Management Market Share Analysis (%) By Drug Class, 2022 & 2031

Figure 130: BENELUX Postoperative Pain Management Market Share Analysis (%) By Route of Administration, 2022 & 2031

Figure 131: BENELUX Postoperative Pain Management Market Share Analysis (%) By Distribution Channel, 2022 & 2031

Figure 132: Spain Market Value Proportion Analysis

Figure 133: Global Vs. Spain Growth Comparison

Figure 134: Spain Postoperative Pain Management Market Share Analysis (%) By Drug Class, 2022 & 2031

Figure 135: Spain Postoperative Pain Management Market Share Analysis (%) By Route of Administration, 2022 & 2031

Figure 136: Spain Postoperative Pain Management Market Share Analysis (%) By Distribution Channel, 2022 & 2031

Figure 137: Russia Market Value Proportion Analysis

Figure 138: Global Vs. Russia Growth Comparison

Figure 139: Russia Postoperative Pain Management Market Share Analysis (%) By Drug Class, 2022 & 2031

Figure 140: Russia Postoperative Pain Management Market Share Analysis (%) By Route of Administration, 2022 & 2031

Figure 141: Russia Postoperative Pain Management Market Share Analysis (%) By Distribution Channel, 2022 & 2031

Figure 142: China Market Value Proportion Analysis

Figure 143: Global Vs. China Growth Comparison

Figure 144: China Postoperative Pain Management Market Share Analysis (%) By Drug Class, 2022 & 2031

Figure 145: China Postoperative Pain Management Market Share Analysis (%) By Route of Administration, 2022 & 2031

Figure 146: China Postoperative Pain Management Market Share Analysis (%) By Distribution Channel, 2022 & 2031

Figure 147: Japan Market Value Proportion Analysis

Figure 148: Global Vs. Japan Growth Comparison

Figure 149: Japan Postoperative Pain Management Market Share Analysis (%) By Drug Class, 2022 & 2031

Figure 150: Japan Postoperative Pain Management Market Share Analysis (%) By Route of Administration, 2022 & 2031

Figure 151: Japan Postoperative Pain Management Market Share Analysis (%) By Distribution Channel, 2022 & 2031

Figure 152: South Korea Market Value Proportion Analysis

Figure 153: Global Vs. South Korea Growth Comparison

Figure 154: South Korea Postoperative Pain Management Market Share Analysis (%) By Drug Class, 2022 & 2031

Figure 155: South Korea Postoperative Pain Management Market Share Analysis (%) By Route of Administration, 2022 & 2031

Figure 156: South Korea Postoperative Pain Management Market Share Analysis (%) By Distribution Channel, 2022 & 2031

Figure 157: India Market Value Proportion Analysis

Figure 158: Global Vs. India Growth Comparison

Figure 159: India Postoperative Pain Management Market Share Analysis (%) By Drug Class, 2022 & 2031

Figure 160: India Postoperative Pain Management Market Share Analysis (%) By Route of Administration, 2022 & 2031

Figure 161: India Postoperative Pain Management Market Share Analysis (%) By Distribution Channel, 2022 & 2031

Figure 162: Thailand Market Value Proportion Analysis

Figure 163: Global Vs. Thailand Growth Comparison

Figure 164: Thailand Postoperative Pain Management Market Share Analysis (%) By Drug Class, 2022 & 2031

Figure 165: Thailand Postoperative Pain Management Market Share Analysis (%) By Route of Administration, 2022 & 2031

Figure 166: Thailand Postoperative Pain Management Market Share Analysis (%) By Distribution Channel, 2022 & 2031

Figure 167: Malaysia Market Value Proportion Analysis

Figure 168: Global Vs. Malaysia Growth Comparison

Figure 169: Malaysia Postoperative Pain Management Market Share Analysis (%) By Drug Class, 2022 & 2031

Figure 170: Malaysia Postoperative Pain Management Market Share Analysis (%) By Route of Administration, 2022 & 2031

Figure 171: Malaysia Postoperative Pain Management Market Share Analysis (%) By Distribution Channel, 2022 & 2031

Figure 172: Indonesia Market Value Proportion Analysis

Figure 173: Global Vs. Indonesia Growth Comparison

Figure 174: Indonesia Postoperative Pain Management Market Share Analysis (%) By Drug Class, 2022 & 2031

Figure 175: Indonesia Postoperative Pain Management Market Share Analysis (%) By Route of Administration, 2022 & 2031

Figure 176: Indonesia Postoperative Pain Management Market Share Analysis (%) By Distribution Channel, 2022 & 2031

Figure 177: Australia Market Value Proportion Analysis

Figure 178: Global Vs. Australia Growth Comparison

Figure 179: Australia Postoperative Pain Management Market Share Analysis (%) By Drug Class, 2022 & 2031

Figure 180: Australia Postoperative Pain Management Market Share Analysis (%) By Route of Administration, 2022 & 2031

Figure 181: Australia Postoperative Pain Management Market Share Analysis (%) By Distribution Channel, 2022 & 2031

Figure 182: New Zealand Market Value Proportion Analysis

Figure 183: Global Vs. New Zealand Growth Comparison

Figure 184: New Zealand Postoperative Pain Management Market Share Analysis (%) By Drug Class, 2022 & 2031

Figure 185: New Zealand Postoperative Pain Management Market Share Analysis (%) By Route of Administration, 2022 & 2031

Figure 186: New Zealand Postoperative Pain Management Market Share Analysis (%) By Distribution Channel, 2022 & 2031

Figure 187: GCC Countries Market Value Proportion Analysis

Figure 188: Global Vs. GCC Countries Growth Comparison

Figure 189: GCC Countries Postoperative Pain Management Market Share Analysis (%) By Drug Class, 2022 & 2031

Figure 190: GCC Countries Postoperative Pain Management Market Share Analysis (%) By Route of Administration, 2022 & 2031

Figure 191: GCC Countries Postoperative Pain Management Market Share Analysis (%) By Distribution Channel, 2022 & 2031

Figure 192: South Africa Market Value Proportion Analysis

Figure 193: Global Vs. South Africa Growth Comparison

Figure 194: South Africa Postoperative Pain Management Market Share Analysis (%) By Drug Class, 2022 & 2031

Figure 195: South Africa Postoperative Pain Management Market Share Analysis (%) By Route of Administration, 2022 & 2031

Figure 196: South Africa Postoperative Pain Management Market Share Analysis (%) By Distribution Channel, 2022 & 2031

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy
Google translate